Refining Prognosis of Early Stage Lung Cancer by Molecular Features (Part 3): Evidence to Support a New, Biology-Based Staging System (audio
20 mag 2013 ·
19 min. 28 sec.
![Refining Prognosis of Early Stage Lung Cancer by Molecular Features (Part 3): Evidence to Support a New, Biology-Based Staging System (audio](https://d3wo5wojvuv7l.cloudfront.net/t_square_limited_480/images.spreaker.com/original/b6126a743222ee1701baf07a1b427d04.jpg)
Scarica e ascolta ovunque
Scarica i tuoi episodi preferiti e goditi l'ascolto, ovunque tu sia! Iscriviti o accedi ora per ascoltare offline.
Descrizione
Dr. Johannes Kratz, surgeon at Massachusetts General Hospital, reviews data supporting a method to define prognosis in early stage non-small cell lung cancer (NSCLC) based on molecular signatures and proposes...
mostra di più
Dr. Johannes Kratz, surgeon at Massachusetts General Hospital, reviews data supporting a method to define prognosis in early stage non-small cell lung cancer (NSCLC) based on molecular signatures and proposes a new staging system.
mostra meno
Informazioni
Autore | cancerGRACE |
Sito | - |
Tag |
Copyright 2024 - Spreaker Inc. an iHeartMedia Company